Physician's Weekly
JUNE 19, 2025
Had she signed up for the government insurance plan when she turned 65, Diamond could have avoided a financially perilous situation that left her unexpectedly responsible for the medical costs she incurred during that time. Some of those providers are now seeking payment from her. “It’s horrifying,” she said.
FDA Law
JUNE 30, 2022
As the drug distribution industry is well aware, and as blogged about here , on February 4, 2022, FDA published its long-awaited proposed rule titled “ National Standards for the Licensure of Wholesale Drug Distributors and Third-party Logistic Providers ” (87 Fed. 2) State regulation of third-party logistics providers. 6,708 (Feb.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BMJ
AUGUST 20, 2021
Donors, government ministries, agencies and academic partners regularly cascade requests for data that multiply and complicate the simple interaction into a complex, and often redundant, set of data requirements for the same singular interaction. Mobile phone penetration has finally exceeded 90% in low- and middle-income countries.
FDA Law
JANUARY 15, 2024
Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. By David B. Clissold & Sara W. FDA said randomized clinical trials could be used, but so could observational studies with respect to cessation data.
FDA Law
NOVEMBER 16, 2021
5376 that has garnered the greatest amount of attention (at least in the food and drug law world) is TITLE XIII, Subtitle J (Drug Pricing), Part 1 (Lowering Prices Through Fair Drug Price Negotiation), Section 139001 (Providing for Lower Prices for Certain High-Priced Single Source Drugs). One of the new programs included in the H.R.
33 Charts
OCTOBER 2, 2021
Inconsistency in care delivery So as every provider shapes her practice around MyChart, each will do it in a slightly different way. But this may not be consistently applied by other providers in the same group. A few ideas: Stronger technology governance of MyChart messages We want to call the MyChart mushroom an Epic problem.
FDA Law
JANUARY 11, 2024
Notably, the purpose of the statute seemed to govern much of FDA’s interpretation. This all sounds complicated, I know. Koblitz — Back in late September 2023 (and corrected in October), FDA issued its first interchangeable exclusivity determination pursuant to the Biologics Price Competition and Innovation Act (“BPCIA”).
Expert insights. Personalized for you.
52 
Let's personalize your content